In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
In a short-term perspective, the company has interesting fundamentals.
Strengths
The company shows low valuation levels, with an enterprise value at 219.43 times its sales.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts covering this company mostly recommend stock overweighting or purchase.
The stock is in a well-established, long-term rising trend above the technical support level at 182500 KRW
Weaknesses
The stock is close to a major daily resistance at KRW 341500, which should be gotten rid of so as to gain new appreciation potential.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
Low profitability weakens the company.
The group shows a rather high level of debt in proportion to its EBITDA.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
With an expected P/E ratio at 58.93 and 21.85 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the past year, analysts have significantly revised downwards their profit estimates.